Baroda BNP Paribas Dividend Yield Fund
The scheme seeks to provide medium to long term appreciation by predominantly investing in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies. There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 2/5 — ranked #112 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹8.99 (as of 2026-10-23) |
|---|
| AUM | ₹532 Cr |
|---|
| Expense ratio | 2.06% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Himanshu Singh |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −18.73% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 51.1% of NIFTY Alpha 50's upside and 57.9% of its downside.
Market cap allocation
| Large cap | 67.2% |
|---|
| Mid cap | 29.9% |
|---|
| Small cap | 3.0% |
|---|
Concentration
| Top 5 holdings | 25.9% |
|---|
| Top 10 holdings | 41.4% |
|---|
| Total holdings | 44 |
|---|
Top holdings
- Reliance Industries Ltd — 6.5%
- ICICI Bank Ltd. — 5.5%
- Clearing Corporation of India Ltd — 5.0%
- HDFC Bank Ltd. — 4.8%
- Larsen & Toubro Limited — 4.7%
- Torrent Pharmaceuticals Ltd. — 4.3%
- Divis Laboratories Ltd. — 3.5%
- GlaxoSmithkline Pharmaceuticals Ltd. — 3.3%
- Radico Khaitan Ltd. — 3.3%
- Hero MotoCorp Limited — 2.8%
Top sectors
- Banking & Financial — 18.4%
- Pharma & Biotech — 13.0%
- Automobile — 12.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −9.0% | Q3 | #105 of 167 |
| 2025 | 5.5% | Q2 | #52 of 132 |